Share

PIC 'fears foreign control of Adcock'

Johannesburg - The state-owned Public Investment Corporation (PIC) is opposing the takeover of drugs firm Adcock Ingram [JSE:AIP] by Chile's CFR Pharmaceutical because of concerns about foreign control and the share component of the deal, a source familiar with the fund's thinking said on Tuesday.

The PIC, Adcock's largest shareholder with a 14% direct stake, has given only  vague reasons for its rejection of the R13.48bn ($1.3bn) deal, saying it was not in its "best interest".

However, the source, who asked not be identified because the matter is private, said the PIC was concerned about a South African company falling into foreign hands, citing uncertainty about the type of management CFR would bring.

"If we think management can't take this company forward, let's change the management, not ownership," the source said.

CFR threatened this week to pull out if it does not win support from the PIC, whose objections are symptomatic of the ambivalence in Pretoria towards foreign investment and ownership.

Although South Africa desperately needs foreign capital and expertise, Pretoria has a history of sinking cross-border deals if they are seen to threaten initiatives designed to raise the living standards of the black majority.

Last year, it rejected a $385m bid by South Korea's KT Corp for a stake in fixed-line operator Telkom, and in 2011 its labour and local supplier demands almost scuppered Walmart's $2.4bn takeover of retailer Massmart.

Santiago-based CFR said in September it would pay R12.6bn in cash and shares for South Africa's second-largest drug maker, which also supplies equipment to public hospitals and HIV/Aids antiretroviral drugs.

The deal amounts to as much as R47.29 in cash per Adcock share and up to 15.44 new CFR shares per Adcock share.

However, the source said the PIC also objected to the share component of the deal.

"CFR's shares are way overvalued. I believe we are being short-changed here," the source said.

Adcock has underperformed operationally and in the stock market, with some shareholders blaming management for failing to keep up with larger rival Aspen Pharmacare, which has made an aggressive push into overseas markets.

We live in a world where facts and fiction get blurred
Who we choose to trust can have a profound impact on our lives. Join thousands of devoted South Africans who look to News24 to bring them news they can trust every day. As we celebrate 25 years, become a News24 subscriber as we strive to keep you informed, inspired and empowered.
Join News24 today
heading
description
username
Show Comments ()
Rand - Dollar
18.94
-0.2%
Rand - Pound
23.91
-0.1%
Rand - Euro
20.43
+0.2%
Rand - Aus dollar
12.34
+0.1%
Rand - Yen
0.13
-0.2%
Platinum
910.50
+1.5%
Palladium
1,011.50
+1.0%
Gold
2,221.35
+1.2%
Silver
24.87
+0.9%
Brent Crude
86.09
-0.2%
Top 40
68,346
+1.0%
All Share
74,536
+0.8%
Resource 10
57,251
+2.8%
Industrial 25
103,936
+0.6%
Financial 15
16,502
-0.1%
All JSE data delayed by at least 15 minutes Iress logo
Company Snapshot
Editorial feedback and complaints

Contact the public editor with feedback for our journalists, complaints, queries or suggestions about articles on News24.

LEARN MORE
Government tenders

Find public sector tender opportunities in South Africa here.

Government tenders
This portal provides access to information on all tenders made by all public sector organisations in all spheres of government.
Browse tenders